We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
+19.05%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$1.5B
AUM Growth
–
Cap. Flow
+$198M
Cap. Flow %
13.22%
Top 10 Hldgs %
43.16%
Holding
169
New
166
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AEGR
Aegerion Pharmaceuticals
AEGR
+$31.5M
2
SRPT icon
Sarepta Therapeutics
SRPT
+$16.3M
3
ABBV icon
AbbVie
ABBV
+$15.6M
4
ZTS icon
Zoetis
ZTS
+$14.9M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$12.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 10.7%
2 Energy 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARIA
126
PUT
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$836K 0.06%
+478
New +$8.47K
MNKD icon
127
MannKind Corp
MNKD
$1.19B
$832K 0.06%
+25,601
New +$686K
TEVA icon
128
Teva Pharmaceuticals
TEVA
$40.4B
$813K 0.05%
+20,736
New +$808K
PBF icon
129
CALL
PBF Energy
PBF
$7.49B
$805K 0.05%
+311
New +$9.25K
BAX icon
130
Baxter International
BAX
$12.8B
$800K 0.05%
+21,269
New +$815K
MNTA
131
CALL
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$786K 0.05%
+522
New +$6.89K
LITS
132
Lite Strategy Inc
LITS
$32.4M
$760K 0.05%
+5,330
New +$886K
DNDN
133
PUT
DELISTED
DENDREON CORPORATION
DNDN
$700K 0.05%
+1,700
New +$7.23K
TCRT icon
134
CALL
Alaunos Therapeutics
TCRT
$4.64M
$688K 0.05%
+22
New +$6.11K
KERX
135
CALL
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$683K 0.05%
+914
New +$7.14K
IMNN icon
136
CALL
Imunon
IMNN
$6.47M
$659K 0.04%
+1
New +$13.9K
PRTK
137
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$610K 0.04%
+16,836
New +$721K
SGYPW
138
CALL
DELISTED
Synergy Pharmaceuticals, Inc. - Warrants
SGYPW
$610K 0.04%
+331,486
New +$775K
NAVB
139
CALL
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$603K 0.04%
+113
New +$5.64K
ONCT
140
CALL
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$578K 0.04%
+1
New +$7.71K
PRTK
141
PUT
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$523K 0.03%
+144
New +$6.17K
ARIA
142
CALL
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$514K 0.03%
+294
New +$5.21K
ATHX
143
DELISTED
Athersys, Inc. Common Stock
ATHX
$499K 0.03%
+12,030
New +$555K
CDMO
144
PUT
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$486K 0.03%
+539
New +$5.65K
INFI
145
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$474K 0.03%
+29,188
New +$903K
VNDA icon
146
Vanda Pharmaceuticals
VNDA
$304M
$459K 0.03%
+56,843
New +$383K
ASTX
147
PUT
DELISTED
ASTEX PHARMACEUTICALS, INC COM
ASTX
$429K 0.03%
+1,043
New +$5.61K
FBIO icon
148
CALL
Fortress Biotech
FBIO
$111M
$420K 0.03%
+33
New +$4.87K
CDMO
149
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$385K 0.03%
+42,600
New +$446K
RPRX
150
CALL
DELISTED
Repros Therapeutics Inc.
RPRX
$369K 0.02%
+200
New +$3.53K
3 4 5
6
7

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
AB
Aozora Bank Tokyo, Japan $43.6M AUM 1.15% 1-Year Est. Return

Sabby Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Sabby Management, which disclosed 169 positions worth $1.5B. Its ten largest holdings account for 43% of the portfolio.

Its largest position is Aegerion Pharmaceuticals: 593,862 shares worth $37.6M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, followed by Energy.

  • Sabby Management's largest Q2 2013 buy was Aegerion Pharmaceuticals: 593,862 shares worth $37.6M.
  • Sabby Management's ten largest holdings make up 43% of its $1.5B portfolio in Q2 2013.
  • Sabby Management disclosed 169 positions in Q2 2013, its first 13F filing on record.

Based on Sabby Management's 13F filing for Q2 2013, filed 14 Aug 2013.